Covestor’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
16
-1
| -6% | – | ﹤0.01% | 2335 |
|
|
2025
Q1 | $0 | Buy |
17
+13
| +325% | – | ﹤0.01% | 2347 |
|
|
2024
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 2355 |
|
|
2024
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 2345 |
|
|
2024
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 2360 |
|
|
2024
Q1 | $0 | Sell |
4
-1
| -20% | – | ﹤0.01% | 2363 |
|
|
2023
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 2275 |
|
|
2023
Q3 | $0 | Buy |
5
+1
| +25% | – | ﹤0.01% | 2254 |
|
|
2023
Q2 | $0 | Buy |
4
+1
| +33% | – | ﹤0.01% | 2260 |
|
|
2023
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 2165 |
|
|
2022
Q4 | $0 | Sell |
3
-1
| -25% | – | ﹤0.01% | 2192 |
|
|
2022
Q3 | $0 | Buy |
4
+1
| +33% | – | ﹤0.01% | 2136 |
|
|
2022
Q2 | $0 | Sell |
3
-2
| -40% | – | ﹤0.01% | 2018 |
|
|
2022
Q1 | $0 | Sell |
5
-1
| -17% | – | ﹤0.01% | 2198 |
|
|
2021
Q4 | $0 | Buy |
+6
| New | – | ﹤0.01% | 2183 |
|